| Year |
Citation |
Score |
| 2024 |
Coleman CR, Pallos J, Arreola-Bustos A, Wang L, Raftery D, Promislow DEL, Martin I. Natural Variation in Age-Related Dopamine Neuron Degeneration is Glutathione-Dependent and Linked to Life Span. Biorxiv : the Preprint Server For Biology. PMID 38405950 DOI: 10.1101/2024.02.12.580013 |
0.538 |
|
| 2022 |
Coleman C, Martin I. Unraveling Parkinson's Disease Neurodegeneration: Does Aging Hold the Clues? Journal of Parkinson's Disease. PMID 36278358 DOI: 10.3233/JPD-223363 |
0.445 |
|
| 2021 |
Kim JW, Yin X, Martin I, Xiong Y, Eacker SM, Ingolia NT, Dawson TM, Dawson VL. Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains. Eneuro. PMID 34759048 DOI: 10.1523/ENEURO.0310-21.2021 |
0.789 |
|
| 2021 |
Pallos J, Jeng S, McWeeney S, Martin I. Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profiling. Neurobiology of Disease. 105390. PMID 33984508 DOI: 10.1016/j.nbd.2021.105390 |
0.469 |
|
| 2020 |
Kim JW, Yin X, Jhaldiyal A, Khan MR, Martin I, Xie Z, Perez-Rosello T, Kumar M, Abalde-Atristain L, Xu J, Chen L, Eacker SM, Surmeier DJ, Ingolia NT, Dawson TM, et al. Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis. Cell Stem Cell. PMID 32846140 DOI: 10.1016/J.Stem.2020.08.002 |
0.613 |
|
| 2020 |
Chittoor-Vinod VG, Villalobos-Cantor S, Roshak H, Shea K, Abalde-Atristain L, Martin I. Dietary Amino Acids Impact LRRK2-induced Neurodegeneration in Parkinson's Disease Models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32605938 DOI: 10.1523/Jneurosci.2809-19.2020 |
0.803 |
|
| 2018 |
Lavoy S, Chittoor-Vinod VG, Chow CY, Martin I. Genetic Modifiers of Neurodegeneration in a Model of Parkinson's Disease. Genetics. PMID 29907646 DOI: 10.1534/genetics.118.301119 |
0.41 |
|
| 2016 |
Martin I, Chittoor VG. Parkinson disease: Insect screens for PD therapies - keep the flies in. Nature Reviews. Neurology. PMID 27125634 DOI: 10.1038/nrneurol.2016.56 |
0.396 |
|
| 2016 |
Martin I, Kim JW, Dawson VL, Dawson TM. LRRK2 pathobiology in Parkinson's disease - virtual inclusion. Journal of Neurochemistry. PMID 26899799 DOI: 10.1111/Jnc.13549 |
0.613 |
|
| 2016 |
Martin I. Decoding Parkinson's Disease Pathogenesis: The Role of Deregulated mRNA Translation. Journal of Parkinson's Disease. PMID 26889638 DOI: 10.3233/JPD-150738 |
0.318 |
|
| 2016 |
Karuppagounder SS, Xiong Y, Lee Y, Lawless MC, Kim D, Nordquist E, Martin I, Ge P, Brahmachari S, Jhaldiyal A, Kumar M, Andrabi SA, Dawson TM, Dawson VL. LRRK2 G2019S Transgenic Mice Display Increased Susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Mediated Neurotoxicity. Journal of Chemical Neuroanatomy. PMID 26808467 DOI: 10.1016/J.Jchemneu.2016.01.007 |
0.691 |
|
| 2014 |
Martin I, Abalde-Atristain L, Kim JW, Dawson TM, Dawson VL. Abberant protein synthesis in G2019S LRRK2 Drosophila Parkinson disease-related phenotypes. Fly. 8: 165-9. PMID 25483009 DOI: 10.4161/19336934.2014.983382 |
0.811 |
|
| 2014 |
Martin I, Kim JW, Dawson VL, Dawson TM. LRRK2 pathobiology in Parkinson's disease. Journal of Neurochemistry. 131: 554-65. PMID 25251388 DOI: 10.1111/Jnc.12949 |
0.725 |
|
| 2014 |
Martin I, Kim JW, Lee BD, Kang HC, Xu JC, Jia H, Stankowski J, Kim MS, Zhong J, Kumar M, Andrabi SA, Xiong Y, Dickson DW, Wszolek ZK, Pandey A, et al. Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. Cell. 157: 472-85. PMID 24725412 DOI: 10.1016/J.Cell.2014.01.064 |
0.792 |
|
| 2011 |
Martin I, Dawson VL, Dawson TM. Recent advances in the genetics of Parkinson's disease. Annual Review of Genomics and Human Genetics. 12: 301-25. PMID 21639795 DOI: 10.1146/Annurev-Genom-082410-101440 |
0.65 |
|
| 2010 |
Martin I, Dawson VL, Dawson TM. The impact of genetic research on our understanding of Parkinson's disease. Progress in Brain Research. 183: 21-41. PMID 20696313 DOI: 10.1016/S0079-6123(10)83002-X |
0.642 |
|
| Show low-probability matches. |